365 related articles for article (PubMed ID: 9337376)
1. Efficacy of the rhesus rotavirus-based quadrivalent vaccine in infants and young children in Venezuela.
Pérez-Schael I; Guntiñas MJ; Pérez M; Pagone V; Rojas AM; González R; Cunto W; Hoshino Y; Kapikian AZ
N Engl J Med; 1997 Oct; 337(17):1181-7. PubMed ID: 9337376
[TBL] [Abstract][Full Text] [Related]
2. Safety and efficacy of high-dose rhesus-human reassortant rotavirus vaccines--report of the National Multicenter Trial. United States Rotavirus Vaccine Efficacy Group.
Rennels MB; Glass RI; Dennehy PH; Bernstein DI; Pichichero ME; Zito ET; Mack ME; Davidson BL; Kapikian AZ
Pediatrics; 1996 Jan; 97(1):7-13. PubMed ID: 8545227
[TBL] [Abstract][Full Text] [Related]
3. Horizontal transmission of rhesus monkey rotavirus-based quadrivalent vaccine during a phase 3 clinical trial in Caracas, Venezuela.
Hoshino Y; Wagner M; Yan XY; Perez-Schael I; Kapikian AZ
J Infect Dis; 2003 Mar; 187(5):791-800. PubMed ID: 12599053
[TBL] [Abstract][Full Text] [Related]
4. Rhesus Rotavirus candidate vaccine. Clinical trial in children vaccinated between 2 and 5 months of age.
Vesikari T; Rautanen T; Varis T; Beards GM; Kapikian AZ
Am J Dis Child; 1990 Mar; 144(3):285-9. PubMed ID: 2154925
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of RIX4414, a live, attenuated rotavirus vaccine, in a randomized, double-blind, placebo-controlled phase 2 trial involving 2464 Singaporean infants.
Phua KB; Quak SH; Lee BW; Emmanuel SC; Goh P; Han HH; De Vos B; Bock HL
J Infect Dis; 2005 Sep; 192 Suppl 1():S6-S16. PubMed ID: 16088807
[TBL] [Abstract][Full Text] [Related]
6. Effects of the potency and composition of the multivalent human-bovine (WC3) reassortant rotavirus vaccine on efficacy, safety and immunogenicity in healthy infants.
Vesikari T; Clark HF; Offit PA; Dallas MJ; DiStefano DJ; Goveia MG; Ward RL; Schödel F; Karvonen A; Drummond JE; DiNubile MJ; Heaton PM
Vaccine; 2006 May; 24(22):4821-9. PubMed ID: 16621194
[TBL] [Abstract][Full Text] [Related]
7. Randomised placebo-controlled trial of rhesus-human reassortant rotavirus vaccine for prevention of severe rotavirus gastroenteritis.
Joensuu J; Koskenniemi E; Pang XL; Vesikari T
Lancet; 1997 Oct; 350(9086):1205-9. PubMed ID: 9652561
[TBL] [Abstract][Full Text] [Related]
8. Dose response and efficacy of a live, attenuated human rotavirus vaccine in Mexican infants.
Ruiz-Palacios GM; Guerrero ML; Bautista-Márquez A; Ortega-Gallegos H; Tuz-Dzib F; Reyes-González L; Rosales-Pedraza G; Martínez-López J; Castañón-Acosta E; Cervantes Y; Costa-Clemens S; DeVos B
Pediatrics; 2007 Aug; 120(2):e253-61. PubMed ID: 17606534
[TBL] [Abstract][Full Text] [Related]
9. Efficacy, immunogenicity, and safety of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine at the end of shelf life.
Block SL; Vesikari T; Goveia MG; Rivers SB; Adeyi BA; Dallas MJ; Bauder J; Boslego JW; Heaton PM;
Pediatrics; 2007 Jan; 119(1):11-8. PubMed ID: 17200266
[TBL] [Abstract][Full Text] [Related]
10. Safety, efficacy, and immunogenicity of 2 doses of bovine-human (UK) and rhesus-rhesus-human rotavirus reassortant tetravalent vaccines in Finnish children.
Vesikari T; Karvonen AV; Majuri J; Zeng SQ; Pang XL; Kohberger R; Forrest BD; Hoshino Y; Chanock RM; Kapikian AZ
J Infect Dis; 2006 Aug; 194(3):370-6. PubMed ID: 16826486
[TBL] [Abstract][Full Text] [Related]
11. Immunogenicity, safety and efficacy of tetravalent rhesus-human, reassortant rotavirus vaccine in Belém, Brazil.
Linhares AC; Gabbay YB; Mascarenhas JD; de Freitas RB; Oliveira CS; Bellesi N; Monteiro TA; Lins-Lainson Z; Ramos FL; Valente SA
Bull World Health Organ; 1996; 74(5):491-500. PubMed ID: 9002329
[TBL] [Abstract][Full Text] [Related]
12. A short report on highlights of world-wide development of RIX4414: a Latin American experience.
Linhares AC; Ruiz-Palacios GM; Guerrero ML; Salinas B; Perez-Schael I; Clemens SA; Innis B; Yarzabal JP; Vespa G; Cervantes Y; Hardt K; De Vos B
Vaccine; 2006 May; 24(18):3784-5. PubMed ID: 16098636
[TBL] [Abstract][Full Text] [Related]
13. Live attenuated human rotavirus vaccine, Rotarix.
Bernstein DI
Semin Pediatr Infect Dis; 2006 Oct; 17(4):188-94. PubMed ID: 17055369
[TBL] [Abstract][Full Text] [Related]
14. Safety, efficacy, and immunogenicity of a live, quadrivalent human-bovine reassortant rotavirus vaccine in healthy infants.
Clark HF; Bernstein DI; Dennehy PH; Offit P; Pichichero M; Treanor J; Ward RL; Krah DL; Shaw A; Dallas MJ; Laura D; Eiden JJ; Ivanoff N; Kaplan KM; Heaton P
J Pediatr; 2004 Feb; 144(2):184-90. PubMed ID: 14760258
[TBL] [Abstract][Full Text] [Related]
15. [Development of a rotavirus vaccine. Field trials in Venezuela].
Pérez Schael I; Rojas Mazzei AM; Flores J
Acta Cient Venez; 1991; 42(6):296-312. PubMed ID: 1668865
[TBL] [Abstract][Full Text] [Related]
16. Rotavirus vaccines: new drug. Rotavirus infection: one case of severe diarrhoea prevented per 100 vaccinated infants.
Prescrire Int; 2007 Feb; 16(87):3-6. PubMed ID: 17323513
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of rhesus rotavirus monovalent and tetravalent reassortant vaccines in US children. US Rotavirus Vaccine Efficacy Group.
Bernstein DI; Glass RI; Rodgers G; Davidson BL; Sack DA
JAMA; 1995 Apr; 273(15):1191-6. PubMed ID: 7707626
[TBL] [Abstract][Full Text] [Related]
18. [Rotaviruses in human and veterinary medicine].
Dodet B; Heseltine E; Mary C; Saliou P
Sante; 1997; 7(3):195-9. PubMed ID: 9296811
[TBL] [Abstract][Full Text] [Related]
19. Immunogenicity, safety and protective efficacy of one dose of the rhesus rotavirus vaccine and serotype 1 and 2 human-rhesus rotavirus reassortants in children from Lima, Peru.
Lanata CF; Black RE; Flores J; Lazo F; Butron B; Linares A; Huapaya A; Ventura G; Gil A; Kapikian AZ
Vaccine; 1996 Feb; 14(3):237-43. PubMed ID: 8920706
[TBL] [Abstract][Full Text] [Related]
20. Neonatal administration of rhesus rotavirus tetravalent vaccine.
Vesikari T; Karvonen A; Forrest BD; Hoshino Y; Chanock RM; Kapikian AZ
Pediatr Infect Dis J; 2006 Feb; 25(2):118-22. PubMed ID: 16462287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
